XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 31.05.2024

Das Instrument 8VY DK0061031895 SCANDION ONC. DK-,0735 EQUITY wird ex Kapitalmassnahme gehandelt am 31.05.2024
The instrument 8VY DK0061031895 SCANDION ONC. DK-,0735 EQUITY is traded ex capital adjustment on 31.05.2024

Das Instrument ZHY KYG989761062 ZHOU HEI YA HLDG -,000001 EQUITY wird cum Kapitalmassnahme gehandelt am 31.05.2024 und ex Kapitalmassnahme am 03.06.2024
The instrument ZHY KYG989761062 ZHOU HEI YA HLDG -,000001 EQUITY is traded cum capital adjustment on 31.05.2024 and ex capital adjustment on 03.06.2024

Das Instrument 36M US82489T1043 SHOCKWAVE MEDICAL DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 31.05.2024 und ex Kapitalmassnahme am 03.06.2024
The instrument 36M US82489T1043 SHOCKWAVE MEDICAL DL-,001 EQUITY is traded cum capital adjustment on 31.05.2024 and ex capital adjustment on 03.06.2024

Das Instrument 0VU1 KYG5700Y2097 LUFAX HLDG.L. A DL-,00001 EQUITY wird cum Kapitalmassnahme gehandelt am 31.05.2024 und ex Kapitalmassnahme am 03.06.2024
The instrument 0VU1 KYG5700Y2097 LUFAX HLDG.L. A DL-,00001 EQUITY is traded cum capital adjustment on 31.05.2024 and ex capital adjustment on 03.06.2024

Das Instrument E17 CA2927661025 ENERPLUS CORP. EQUITY wird ex Kapitalmassnahme gehandelt am 31.05.2024
The instrument E17 CA2927661025 ENERPLUS CORP. EQUITY is traded ex capital adjustment on 31.05.2024

Das Instrument 1YG SE0005003654 MENDUS AB EQUITY wird cum Kapitalmassnahme gehandelt am 31.05.2024 und ex Kapitalmassnahme am 03.06.2024
The instrument 1YG SE0005003654 MENDUS AB EQUITY is traded cum capital adjustment on 31.05.2024 and ex capital adjustment on 03.06.2024

Das Instrument GDO3 CA77536Q2027 ROGUE RES INC. EQUITY wird cum Kapitalmassnahme gehandelt am 31.05.2024 und ex Kapitalmassnahme am 03.06.2024
The instrument GDO3 CA77536Q2027 ROGUE RES INC. EQUITY is traded cum capital adjustment on 31.05.2024 and ex capital adjustment on 03.06.2024

5 heiße Wetten für den Jahresendspurt!

Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Hier klicken

Zeit	Aktuelle Nachrichten
12.11.	Clean Energy Transition Inc: Clean Energy estimates Aurora historical resource
12.11.	Clean Energy Transition Inc.: transition.inc Announces the Aurora Nickel Project, Updated Mineral Resource Estimate Now In-Process, Management Presenting at Benchmark Week in USA	TORONTO, ON / ACCESSWIRE / November 12, 2024 / Clean Energy Transition Inc. (TSXV:TRAN) ("transition.inc" or the "Company") is pleased to announce details of its previously-acquired Aurora Nickel Project... ► Artikel lesen
06.11.	Clean Energy Transition Inc: Clean Energy begins quartz production from Snow White
06.11.	Clean Energy Transition Inc.: transition.inc Begins Production From the Snow White Quartz Project in Ontario, Management Presenting at Investor Conference in Toronto	TORONTO, ON / ACCESSWIRE / November 6, 2024 / Clean Energy Transition Inc. (TSX-V:TRAN) ("transition.inc" or the "Company") is pleased to announce initial quartz production from the Snow White Project... ► Artikel lesen
01.11.	Clean Energy Transition Inc: Clean Energy swallows poison pill,

Zeit

Aktuelle Nachrichten

12.11.

Clean Energy Transition Inc: Clean Energy estimates Aurora historical resource

12.11.

Clean Energy Transition Inc.: transition.inc Announces the Aurora Nickel Project, Updated Mineral Resource Estimate Now In-Process, Management Presenting at Benchmark Week in USA

TORONTO, ON / ACCESSWIRE / November 12, 2024 / Clean Energy Transition Inc. (TSXV:TRAN) ("transition.inc" or the "Company") is pleased to announce details of its previously-acquired Aurora Nickel Project...
► Artikel lesen

06.11.

Clean Energy Transition Inc: Clean Energy begins quartz production from Snow White

06.11.

Clean Energy Transition Inc.: transition.inc Begins Production From the Snow White Quartz Project in Ontario, Management Presenting at Investor Conference in Toronto

TORONTO, ON / ACCESSWIRE / November 6, 2024 / Clean Energy Transition Inc. (TSX-V:TRAN) ("transition.inc" or the "Company") is pleased to announce initial quartz production from the Snow White Project...
► Artikel lesen

01.11.

Clean Energy Transition Inc: Clean Energy swallows poison pill,

Zeit	Aktuelle Nachrichten
08.11.	Mendus AB: Mendus AB Interim Report January - September 2024	Press ReleaseStockholm, Sweden, November 8, 2024"In the third quarter of 2024, Mendus has focused on expanding the clinical development for vididencel in acute myeloid leukemia (AML) and progressing... ► Artikel lesen
27.08.	Mendus - Broad progress across the pipeline	Mendus's Q224 results reflect a period of steady progress across its clinical programmes. For vididencel, the Phase II CADENCE trial (for acute myeloid leukaemia, AML) is now ready to commence patient... ► Artikel lesen
23.08.	Mendus AB: Mendus AB Interim Report January - June 2024	Press ReleaseStockholm, Sweden, August 23, 2024Data Reported in Q2 Confirm that Vididencel Acts as Active Immunotherapy in AMLIn the second quarter of 2024, Mendus reported in-depth immunological data... ► Artikel lesen
24.07.	Mendus - Collaboration unveils path forward for ilixadencel	Mendus has announced a collaboration with Institut Bergonié, an established comprehensive cancer centre in France, to test ilixadencel in soft tissue sarcomas (STS) as part of an ongoing Phase I/II... ► Artikel lesen
03.06.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.06.2024	The following instruments on XETRA do have their first trading 03.06.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.06.2024 Aktien 1 US0071921078 Admiral Group PLC ADR 2... ► Artikel lesen

Zeit

Aktuelle Nachrichten

08.11.

Mendus AB: Mendus AB Interim Report January - September 2024

Press ReleaseStockholm, Sweden, November 8, 2024"In the third quarter of 2024, Mendus has focused on expanding the clinical development for vididencel in acute myeloid leukemia (AML) and progressing...
► Artikel lesen

27.08.

Mendus - Broad progress across the pipeline

Mendus's Q224 results reflect a period of steady progress across its clinical programmes. For vididencel, the Phase II CADENCE trial (for acute myeloid leukaemia, AML) is now ready to commence patient...
► Artikel lesen

23.08.

Mendus AB: Mendus AB Interim Report January - June 2024

Press ReleaseStockholm, Sweden, August 23, 2024Data Reported in Q2 Confirm that Vididencel Acts as Active Immunotherapy in AMLIn the second quarter of 2024, Mendus reported in-depth immunological data...
► Artikel lesen

24.07.

Mendus - Collaboration unveils path forward for ilixadencel

Mendus has announced a collaboration with Institut Bergonié, an established comprehensive cancer centre in France, to test ilixadencel in soft tissue sarcomas (STS) as part of an ongoing Phase I/II...
► Artikel lesen

03.06.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.06.2024

The following instruments on XETRA do have their first trading 03.06.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.06.2024 Aktien 1 US0071921078 Admiral Group PLC ADR 2...
► Artikel lesen

Zeit	Aktuelle Nachrichten
30.08.	Nasdaq Stockholm AB: Change of Certified Adviser for Scandion Oncology A/S	As from September 1, 2024, Scandion Oncology A/S, will change Certified Adviser to Vator Securities AB. This information is distributed at the request of the Certified Adviser, Västra Hamnen Corporate... ► Artikel lesen
18.07.	Nasdaq Stockholm AB: New equity right for trading, Scandion Oncology A/S TO 2	At the request of Scandion Oncology, Scandion Oncology equity rights will be traded on First North Growth Market as from July 19, 2024. Security name: Scandion Oncology TO 2 -------------------------------------- Short... ► Artikel lesen
18.07.	Nasdaq Stockholm AB: New equity right for trading, Scandion Oncology A/S TO 3	At the request of Scandion Oncology, Scandion Oncology equity rights will be traded on First North Growth Market as from July 19, 2024. Security name: Scandion Oncology TO 3 -------------------------------------- Short... ► Artikel lesen
11.07.	Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of Scandion Oncology	At the request of Scandion Oncology, the last trading day in Scandion Oncology's paid subscription units will be changed from 2024-07-11 to 2024-07-15. Instrument: Paid subscription units... ► Artikel lesen
04.06.	Nasdaq Stockholm AB: Listing of subscription units and paid subscription units of Scandion Oncology	With effect from June 05, 2024, the subscription units in Scandion Oncology will be traded on First North Growth Market. Trading will continue up until and including June 17, 2024. Instrument:... ► Artikel lesen

Zeit

Aktuelle Nachrichten

30.08.

Nasdaq Stockholm AB: Change of Certified Adviser for Scandion Oncology A/S

As from September 1, 2024, Scandion Oncology A/S, will change Certified Adviser to Vator Securities AB. This information is distributed at the request of the Certified Adviser, Västra Hamnen Corporate...
► Artikel lesen

18.07.

Nasdaq Stockholm AB: New equity right for trading, Scandion Oncology A/S TO 2

At the request of Scandion Oncology, Scandion Oncology equity rights will be traded on First North Growth Market as from July 19, 2024. Security name: Scandion Oncology TO 2 -------------------------------------- Short...
► Artikel lesen

18.07.

Nasdaq Stockholm AB: New equity right for trading, Scandion Oncology A/S TO 3

At the request of Scandion Oncology, Scandion Oncology equity rights will be traded on First North Growth Market as from July 19, 2024. Security name: Scandion Oncology TO 3 -------------------------------------- Short...
► Artikel lesen

11.07.

Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of Scandion Oncology

At the request of Scandion Oncology, the last trading day in Scandion Oncology's paid subscription units will be changed from 2024-07-11 to 2024-07-15. Instrument: Paid subscription units...
► Artikel lesen

04.06.

Nasdaq Stockholm AB: Listing of subscription units and paid subscription units of Scandion Oncology

With effect from June 05, 2024, the subscription units in Scandion Oncology will be traded on First North Growth Market. Trading will continue up until and including June 17, 2024. Instrument:...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Di	ZHOU HEI YA (01458): NEXT DAY DISCLOSURE RETURN
11.11.	ZHOU HEI YA (01458): NEXT DAY DISCLOSURE RETURN
01.11.	ZHOU HEI YA (01458): NEXT DAY DISCLOSURE RETURN
24.10.	ZHOU HEI YA (01458): NEXT DAY DISCLOSURE RETURN
17.10.	ZHOU HEI YA (01458): NEXT DAY DISCLOSURE RETURN

Zeit

Aktuelle Nachrichten